Document is current

Any future updates will be listed below

One-year results of treat-and-extend regimen with intravitreal brolucizumab for treatment-naïve neovascular age-related macular degeneration with type 1 macular neovascularization

Crossref DOI link: https://doi.org/10.1038/s41598-022-10578-1

Published Online: 2022-05-17

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark